注册登记系统在外科补片上市后监测中的重要性
该研究基于Herniamed注册登记系统,比较腹腔镜腹腔内补片修补术中使用Physiomesh(n=1380)与其他指南推荐补片(n=3834)的切口疝患者数据。结果显示Physiomesh组1年复发率显著更高(12.0% vs 5.0%,P<0.001),多变量分析中补片类型对复发率有高度显著影响(P<0.001),使用Physiomesh的复发风险比值比为2.570(95%CI 2.057,3.210)。
要点
- Physiomesh组1年复发率12.0%,显著高于其他推荐补片的5.0%(P<0.001)。
- 多变量分析显示补片类型对复发率有高度显著影响(P<0.001)。
- 使用Physiomesh的1年复发风险比值比为2.570(95%CI 2.057,3.210)。
核心结论
- 基于注册登记系统的真实世界数据可有效用于外科补片的上市后监测,本研究表明Physiomesh与其他指南推荐补片相比1年复发率显著更高。
研究设计与样本
- 基于Herniamed德国注册登记系统的前瞻性围手术期及1年随访数据分析,比较择期腹腔镜腹腔内补片修补术中使用Physiomesh(n=1380)与其他指南推荐补片(n=3834)的切口疝患者。
主要发现
- Physiomesh组1年复发率为12.0%,其他推荐补片组为5.0%,差异显著(P<0.001)。
- 多变量分析中补片类型对复发率有高度显著影响(P<0.001)。
- 使用Physiomesh的1年随访复发率比值比为2.570(95%CI 2.057,3.210)。
- 补片类型对慢性疼痛发生率也有显著影响。
临床怎么用
- 外科医生在选择补片时应关注注册登记系统提供的上市后真实世界数据,尤其是复发和慢性疼痛等结局。
- 对于腹腔镜腹腔内补片修补术,需权衡不同补片的复发风险,Physiomesh与更高的1年复发率相关。
局限性
- 本研究基于注册登记系统数据,非随机对照设计,可能存在混杂偏倚。
- 原文指出需要随机对照试验用于新器械的上市前批准,且需考虑器械研究由制造公司赞助的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the role of registries in the postmarketing surveillance of surgical meshes. BACKGROUND: To date, surgical meshes are classified as group II medical devices. Class II devices do not require premarket clearance by clinical studies. Ethicon initiated a voluntary market withdrawal of Physiomesh for laparoscopic use after an analysis of unpublished data from the 2 large independent hernia registries-Herniamed German Registry and Danish Hernia Database. This paper now presents the relevant data from the Herniamed Registry. METHODS: The present analysis compares the prospective perioperative and 1-year follow-up data collected for all patients with incisional hernia who had undergone elective laparoscopic intraperitoneal onlay mesh repair either with Physiomesh (n = 1380) or with other meshes recommended in the guidelines (n = 3834). RESULTS: Patients with Physiomesh repair had a markedly higher recurrence rate compared with the other recommended meshes (12.0% vs 5.0%; P < 0.001). In the multivariable analysis, the recurrence rate was highly significantly influenced by the mesh type used (P < 0.001). If Physiomesh was used, that led to a highly significant increase in the recurrence rate on 1-year follow-up (odds ratio 2.570, 95% CI 2.057, 3.210). The mesh type used also had a significant influence on chronic pain rates. CONCLUSIONS: The importance of real-world data for postmarketing surveillance of surgical meshes has been demonstrated in this registry-based study. Randomized controlled trials are needed for premarket approval of new devices. The role of sponsorship of device studies by the manufacturing company must be taken into account.
引用
- Köckerling F, Simon T, Hukauf M, et al. The Importance of Registries in the Postmarketing Surveillance of Surgical Meshes. Ann Surg. 2018. PMID: 28594740. doi:10.1097/SLA.0000000000002326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。